
Solvemed
Digitized Ocular Biomarker for Neurological Disease Diagnosis
Solvemed
Digital Biomarker
|
Cambridge, UK
About
Solvemed develops a digitized ocular biomarker for neurological disease diagnosis. Using a smartphone-based pupil light reflex exam and proprietary analytics, its technology supports earlier detection and monitoring of disorders such as Parkinson's disease.
Founders
Co-Investors
ATMOS Ventures, Sunfish Partners
